Lipella Pharmaceuticals Inc. (LIPO)

NASDAQ: LIPO · IEX Real-Time Price · USD

0.711

+0.007 (0.98%)

At close: Apr 26, 2024, 4:00 PM

0.709

-0.002 (-0.35%)

After-hours: Apr 26, 2024, 6:24 PM EDT

Lipella Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	4	6	18	-	-
Market Cap Growth	-	-66.78%	-	-	-
Enterprise Value	1	3	13	-1	-0
PE Ratio	-1.28	-1.28	-6.86	-	-
PS Ratio	9.88	13.17	96.77	-	-
PB Ratio	1.41	1.88	3.81	-	-
P/FCF Ratio	-1.87	-1.87	-9.73	-	-
P/OCF Ratio	-1.88	-1.88	-9.73	-	-
EV/Sales Ratio	2.86	6.14	71.30	-5.30	-0.17
EV/EBITDA Ratio	-0.60	-0.60	-5.07	0.74	3.11
EV/EBIT Ratio	-0.60	-0.60	-5.07	0.74	3.11
EV/FCF Ratio	-0.87	-0.87	-7.17	1.39	5.84
Debt / Equity Ratio	0.04	0.04	0.09	0.24	0.95
Debt / EBITDA Ratio	-0.03	-0.03	-0.17	-0.18	-8.19
Debt / FCF Ratio	-0.04	-0.04	-0.24	-0.34	-15.39
Quick Ratio	8.63	8.63	4.44	5.03	3.25
Current Ratio	8.90	8.90	4.92	5.31	3.37
Asset Turnover	0.12	0.12	0.05	0.18	-
Interest Coverage	-424.79	-424.79	-269.26	-271.97	-6.74
Return on Equity (ROE)	-150.10%	-150.10%	-85.20%	-197.70%	-
Return on Assets (ROA)	-127.20%	-127.20%	-65.20%	-125.70%	-
Return on Capital (ROIC)	-144.65%	-144.65%	-50.69%	-108.59%	-6.30%
Earnings Yield	-103.94%	-78.02%	-14.58%	-	-
FCF Yield	-71.21%	-53.46%	-10.28%	-	-
Buyback Yield / Dilution	-47.84%	-47.84%	-19.15%	36.04%	-
Total Shareholder Return	-47.84%	-47.84%	-19.15%	36.04%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).